IBM is stopping the development and sales of the product, which uses Watson AI to help pharmaceutical companies find new drugs, because it wasn't yielding large enough financial returns, according to a STAT report.
A giant elephant just entered the Valencia Ballroom at the Orange County Convention Center in Orlando, Florida.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
IBM Watson Health and Illumina have formed their very own dream team for tumor sequencing, curation and interpretation. Combined, the two platforms help make cancer genomics more accessible and scalable, but it's the potential for greater scientific standardization that the field needs most.
Every week, we compile the most trafficked and thoughtful stories on MedCity News. Most influential: IBM Watson Health's Anil Jain on issues like alert fatigue, its partnerships, and the benefits of being cloud-based.
Dr. Anil Jain, vice president and CMO of Watson Health, spoke at length to MedCity News last week, and we have it here as a 25-minute podcast.
IBM and the New York Genome Center announced work on a new HIPAA compliant data repository. It will include the entire genome, exome and phenotypic data, which sets it apart from what currently exists in data collection of this kind.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Where does the value come from if companies like Watson Health are essentially just trying to gather big data and sit on it?
Also, the diagnostics industry fights back against FDA scrutiny, a new health tech incubator launches in San Diego and we're getting closer to a halt on the medical device tax.
Salesforce is making a bold entrance into healthcare with its new Health Cloud platform. We'll discuss that and the broader implications of tech-driven population health on this week's MedHeads.
IBM debuted the first of two television commercials highlighting how third-party businesses are building apps on the supercomputing platform, and digital health company Welltok is included. A second ad will feature Watson Health.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A lot of bases in healthcare innovation were covered at CONVERGE this week. We'll reflect back on some highlights.
IBM Watson unveiled a new chapter in its cancer research work, this time for genomic analysis at the World of Watson conference in Brooklyn this week. It will work with 14 institutions spanning research institutes to teaching hospitals to provide access to its data analysis tool. Watson Genomic Analytics looks for variations in the full […]
Members of the MedCity News crew discussed the previous week in healthcare news live in our more recent segment of Medheads.
IBM Watson’s acquisition of Explorys as part of its big announcement at HIMSS this week underscores the growing importance of effective big data analytics tools in healthcare. It also speaks to their perceived value as a way to help patients with chronic conditions avoid incurring unnecessary healthcare costs. CognitiveScale was launched in 2013 by Matt […]
There’s an interesting article in USA Today this week about how IBM approach to its Watson division led to it playing a critical role in making big data less unwieldy, supporting digital health startups and becoming a resource for the healthcare industry. Not bad for a computer brain that got its start as a Jeopardy […]